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Abstract
Objective:  To  evaluate  the  ability  of  a  postnatal  weight-gain  algorithm  (WINROP)  to  identify  sight-threatening
retinopathy of prematurity (ROP type 1) in a nation-based extremely preterm infant cohort.
Methods: This study enrolled all 707 live-born extremely preterm (gestational age [GA] <27 weeks) infants, born
2004–2007  in  Sweden;  the  Extremely  preterm  Infants  in  Sweden  Study  (EXPRESS).  WINROP  analysis  was
performed  retrospectively  in  407  of  the  infants  using  weekly  weight  gain  to  assess  the  preterm  infant’s  risk  of
developing ROP type 1 requiring treatment. GA, birthweight (BW), and weekly postnatal weight measurements were
entered into WINROP. WINROP signals with an alarm to indicate if the preterm infant is at risk for ROP type 1.
Results: In this extremely preterm population, WINROP correctly identified 96% (45/47) of the infants who required
treatment for ROP type 1. The median time from alarm to treatment was 9 weeks (range, 4–20 weeks).
Conclusions: WINROP, an online surveillance system using weekly weight gain, identified extremely preterm infants
at risk for ROP type 1 requiring treatment at an early stage and with high sensitivity in a Swedish nation-based
cohort.
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Introduction
A  significant  improvement  in  survival  amongst  the  most
preterm infants has been noted during the past 15 years [1].
Improved perinatal and neonatal care has lowered the limit of
viability to a gestational age (GA) of 22–23 weeks in countries
with high-quality neonatal intensive care units (NICU) [2].
Retinopathy  of  prematurity  (ROP)  is  a  potentially  sight-
threatening  disease  affecting  premature  infants  [3].  Due  to
pathologic neovascularization of the retina after preterm birth,
the most severe form of ROP (ROP type 1) may lead to retinal
detachment and blindness if untreated [4].
To  identify  infants  in  need  of  treatment,  repeated  eye
examinations  must  be  performed  until  the  retina  is  fully
vascularized.  ROP  eye  examinations  are  one  of  the  more
stressful and painful procedures preterm infants are subjected
to, even when performed by an experienced ophthalmologist
[5].
A  population-based  study  of  extremely  preterm  infants  in
Sweden (EXPRESS) with a GA <27 weeks recently reported
that 20% of extremely preterm infants require treatment [6].
Poor postnatal weight gain during the first weeks of life is a
strong predictor for the development of sight-threatening ROP
type 1 [7-14]. The online monitoring tool, WINROP, developed
in Gothenburg, Sweden, is based on longitudinal weekly weight
measurements and indicates with an alarm if the preterm infant
is at risk of developing sight-threatening ROP.
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e73256The WINROP monitoring tool was introduced and evaluated
with  satisfactory  results  in  different  preterm  populations
worldwide  [13,15,16].  These  studies  have  all  retrospectively
included both very and extremely preterm infants. The aim of
this  study  was  to  retrospectively  evaluate  WINROP  in  a
Swedish nation-based extremely preterm cohort.
Study Population and Methods
Study population
In EXPRESS, all infants born in Sweden before 27 weeks of
gestation  between  April  1,  2004  and  March  31,  2007  were
included.  EXPRESS  is  a  nationwide  project  initiated  by  the
Swedish Association of Perinatology and the Swedish National
Board of Health and Social Welfare. The aim of EXPRESS is to
determine morbidity and mortality rates in extremely premature
infants.  Comprehensive  obstetric  and  neonatal  data  were
collected  prospectively.  GA  at  birth  was  calculated  using
ultrasound  examinations  performed  before  20  weeks  of
gestation. Weight data of every infant throughout their hospital
stay was retrieved from hospital records. Screening for ROP
was  separately  organized  and  the  methods,  examination,
techniques, and results regarding incidence, treatment, natural
history,  and  screening  have  been  described  previously
[6,17,18]. During the study period, 707 infants were born alive
and these infants were included in our study (Figure 1).
WINROP use requires that the infant’s GA is from 23 to 32
gestational weeks at birth, weekly weight measurements, and
physiological  weight  gain  of  <450  g/week.  Infants  with
Figure 1.  Flowchart of the study population.  
doi: 10.1371/journal.pone.0073256.g001
hydrocephalus must be excluded owing to their expected non-
physiological excessive weight gain. Infants who died before 40
weeks of postmenstrual age (PMA) were excluded (n=197) as
ROP grading could be incomplete in these infants. Four infants
born at GA 22 weeks were excluded. Infants without weekly
weight  measurements  up  to  32  weeks  PMA  were  excluded
(n=81). Infants who were diagnosed with hydrocephalus (n=18)
were  excluded.  Finally,  407  infants  met  the  criteria  for  the
WINROP analysis (Figure 1).
ROP examination and treatment
ROP screening started during the fifth postnatal week and
continued  until  the  retina  was  fully  vascularized  or  until
regression of ROP [18]. The eye examinations were performed
according to routine protocol, and consisted of dilated ocular
fundus  examinations.  The  results  of  screening  examinations
were entered into a study screening protocol.
For classification of ROP, the International Classification of
Retinopathy  of  Prematurity  revisited  was  used  [19].  The
recommendations  of  the  Early  Treatment  for  Retinopathy  of
Prematurity  Cooperative  Group  were  followed  for  treatment
[20].  According  to  these  recommendations,  ROP  type  1
requiring treatment is defined as any stage of ROP in zone I
with plus disease; ROP stage 3 in zone I, with or without plus
disease; and ROP in zone II, stage 2 or 3 with plus disease. In
this study, we evaluated the ability of WINROP to predict ROP
type 1.
Data regarding maximum ROP in the worst eye and eventual
treatment were retrieved from the EXPRESS.
WINROP screening
The  online  surveillance  system  WINROP  uses  longitudinal
weekly weight gain to identify infants at risk of developing ROP
type  1.  Each  infant’s  GA,  birthweight  (BW),  and  weekly
postnatal weights; from birth until an alarm is signalled or to a
postmenstrual  age  of  35  to  36  weeks,  were  retrospectively
entered into WINROP by a person unaware of ROP outcome.
The WINROP algorithm estimates the differences between
expected  safe  weekly  weight  gain  and  the  weight  gain
observed,  and  the  values  are  calculated  and  accumulated.
When  the  accumulated  sum  exceeds  a  limit,  an  alarm  is
signalled to indicate that the infant is at risk for severe ROP.
The WINROP outcome is either no alarm or alarm. When the
infant  had  a  record  of  several  weekly  weights  available,  we
chose to enter the weight data closest to a 7 day interval.
Statistical analysis
The negative and positive predictive values were calculated
using the sensitivity, specificity, and prevalence of ROP type 1
for  the  study  group.  95%  confidence  interval  (CIs)  was
calculated.
Ethics Statement
The study was approved by the Regional Research Ethics
Board, Lund University, Lund, Sweden. The parents provided
oral informed consent for data acquisition.
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High prevalence of ROP in the extremely preterm
population
In  this  population,  54%  (219/407)  were  male.  The  median
BW was 784 grams (range, 348–1315 grams), and the median
GA was 25 weeks and 4 days (range 23+0/7 to 26+6/7) (Table
1). ROP was diagnosed in 69.0% (281/407) of the infants. ROP
stages 1–2 developed in 39.8% (162/407). ROP stage 3, not
included in ROP type 1, was diagnosed in 17.7% (72/407) and
ROP  type  1  in  11.5%  (47/407).  All  infants  with  ROP  type  1
received  treatment  (47/47)  as  well  as  26.4%  (19/72)  of  the
infants  with  ROP  stage  3  (Table  1).  No  infant  was  treated
before a PMA of 32 weeks. The infants’ median PMA when
receiving first treatment was 36 weeks (range, 32–47 weeks).
WINROP identifies extremely preterm infants at risk of
ROP type 1 with high sensitivity
An alarm was signalled in 78.4% (319/407) of all infants and
in 95.7% (45/47) of the infants with ROP type 1 (Figure 2). The
specificity  was  23.9%  (86/360).  The  negative  predictive  was
value 97.7% and the positive predictive value 14.1% (Table 2).
WINROP did not signal an alarm in two infants diagnosed
and treated for ROP type 1. Both infants had a complicated
clinical course. One had a partial bowel obstruction, long-term
parenteral  nutrition  and  antibiotic  treatment,  and  received
treatment  at  the  PMA  of  36  weeks.  The  second  infant  had
severe  respiratory  insufficiency,  with  excessive  oxygen
treatment and intraventricular haemorrhage (IVH) grade 4. This
infant was treated in only one eye for ROP type 1 at a PMA of
37 weeks. WINROP did not signal with an alarm in two infants
with ROP stage 3 (ROP type 2; ROP stage 3 in zone II without
Table 1. Alarm Signal in Relation to ROP Categories and
Birth Characteristics.
  Alarm status
  No alarm n=88 Alarm n=319
All infants
n=407
Birth characteristics,
median (range)
 
GA, weeks+days 26+2/7 25+3/7 25+4/7
 
(23+3/7 to
26+6/7)
(23+0/7 to
26+6/7)
(23+0/7 to
26+6/7)
BW, g
978 (714–
1315)
740 (348–1130) 784 (348–1315)
Sex, males n=219 63% (56/88) 51% (163/319) 54% (219/407)
Infants, No. (%) 88 (21.6%) 319 (78.4%) 407
No ROP 38 (30.2%) 88 (69.8%) 126 (31.0%)
ROP stages 1 & 2 38 (23.5%) 124 (76.5%) 162 (39.8%)
ROP stage 3 10 (13.9%) 62 (86.1%) 72 (17.7%)
Type 1 ROP 2 (4.3%) 45 (95.7%) 47 (11.5%)
Treated 4 (6.1%) 62 (93.9%) 66 (16.2%)
Abbreviations:  BW,  birth  weight;  GA,  gestational  age;  ROP,  retinopathy  of
prematurity.
doi: 10.1371/journal.pone.0073256.t001
plus disease) who were treated. One of these infants was only
treated in one eye (Table 3).
Figure 2.  Flowchart of WINROP outcomes.  
doi: 10.1371/journal.pone.0073256.g002
Table  2.  WINROP  Sensitivity,  Specificity,  Positive  and
Negative Predictive Values in Identifying Type 1 ROP.
  Alarm status % (95%CI)
  Alarm No Alarm Total  Sensitivity Specificity
ROP
categories,
No. of infants
 
Type 1 ROP 45 2 47
95.7
(84.3-99.2)
23.9
(19.6-28.7)
Non-type 1
ROP
274 86 360  
Total 319 88 407  
Predictive
value, %
(95%CI)
 
PPV
14.1
(10.5-18.5)
 
NPV  
97.7
(91.2-99.6)
 
Abbreviations:  NPV,  negative  predictive  value;  PPV,  positive  predictive  value;
ROP, retinopathy of prematurity.
doi: 10.1371/journal.pone.0073256.t002
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of developing ROP type 1
The median time from birth to alarm was 3 weeks (range 1–
10 weeks). The infants with ROP type 1 who received an alarm
had  a  median  time  from  alarm  to  first  treatment  of  9  weeks
(range 4–20 weeks) (Figure 3). The infants received their alarm
at least 4 weeks before their treatment.
Table 3. Characteristics of Infants Treated for ROP but not
Signalling a WINROP Alarm.
Infants
GA (weeks
+days) BW
Time at treatment & ROP
type Clinical Course
#1 25+1/7 960g
PMA 37 weeks ROP type
1
Partial bowel obstruction
and long-term parenteral
nutrition.
#2 25+3/7 936g
PMA 38 weeks ROP type
1 One eye treated.
Severe hospital course,
excessive oxygen
treatment, IVH 4
#3 26+3/7 1010g
PMA 36 weeks ROP type
2
No severe complications
#4 26+4/7 910g
PMA 37 weeks ROP type
2, One eye treated
No severe complications
Abbreviations:  BW,  birth  weight;  GA,  gestational  age;  IVH,  intraventricular
hemorrhage; PMA, postmenstrual age; ROP, retinopathy of prematurity
doi: 10.1371/journal.pone.0073256.t003
Figure 3.  Time from birth to the WINROP alarm (A) and
time from the alarm to treatment (infants with ROP type 1)
(B).  
doi: 10.1371/journal.pone.0073256.g003
Discussion
In this first nation based study, WINROP identified extremely
preterm infants with ROP type 1 with high sensitivity (95.7%).
The extremely preterm infant is at high risk of developing ROP,
but also extremely fragile. Every intervention and investigation
must be carefully considered before being implemented owing
to  the  infant’s  vulnerability.  The  ROP  eye  examination  is  a
painful  and  stressful  procedure  [21].  Changes  in  oxygen
saturation, respiratory rate, and heart rate measured during the
examination can be signs of distress [22].
Todays established screening criteria; GA and BW results in
numerous  unnecessary  eye  examinations  to  identify  the
approximately  20%  of  extreme  preterm  infants  in  need  of
treatment. Although it is crucial to correctly identify infants who
require treatment, it would be beneficial if infants not in need of
treatment  could  be  spared  at  least  some  stressful
examinations.  In  the  present  cohort  a  mean  of  11  eye
examinations (range 2–30) were performed/infant. The infants
with  no  ROP  and  no  alarm  had  a  mean  of  6  examinations/
infant. If infants with no alarm and no ROP in this cohort would
have received routine ROP examination at three time points;
PMA  31  weeks,  PMA  33  weeks  and  PMA  36  weeks  these
infants number of examinations would have been reduced by
53%  (130/244).  Even  though  the  number  of  examinations
spared in the whole cohort is limited, for the individual infant,
with  no  alarm  and  no  ROP,  a  reduction  of  half  of  their
examinations could result in an important improvement in their
well-being.
Infants  that  develop  ROP  without  previous  alarm  must,  of
course, depending on the severity of their ROP, be examined
according  to  clinical  judgement  and  present  screening
recommendations.
Two of the infants with ROP type 1 requiring treatment did
not signal an alarm. The main characteristics of these infants
were their severely complicated clinical courses. Thus, when
using  WINROP  to  complement  established  screening
schedules, the clinical judgment regarding the infants’ risk of
developing severe ROP must always supersede the WINROP
outcome.
In this study the sensitivity was 95.7% similar to previously
performed studies in Sweden [11,12]. The specificity of 23.9%
was lower than in previously performed studies in Sweden as
well as in Canada, the U.S, Brazil and Korea [11-13,16,23,24].
The reason for this finding is most likely that the present study
includes a cohort of extremely premature infants, who have the
poorest postnatal weight development and thus are more likely
to signal an alarm in WINROP.
In  this  study,  the  WINROP  alarm  signalled  weeks/months
before  the  development  of  severe  ROP,  giving  the
neonatologist and the ophthalmologist an early prediction of the
infant’s future. In addition to being a sight-threatening disease,
the  severity  of  ROP  is  also  associated  with  later  neurologic
impairment  and  even  death  [25,26].  Severe  ROP  and  poor
early  postnatal  growth  is  a  multifactorial  complication  in  the
preterm  infant.  Maximal  nutritional  support/improved  weight
gain  and  interventions  for  high  risk  infants  may  reduce  the
infants’ long term impairment associated with prematurity [27].
WINROP in an Extremely Preterm Cohort
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IGF-1 levels [28], poor nutritional intake [27], hyperglycaemia
[29,30],  insulin  treatment  [31],  corticosteroid  treatment  [31],
insufficient intake of DHA [32] and, of course, fluctuating/high
oxygen concentrations [33]. An interesting study by Pawlik et al
supplementing  preterm  infants  with  omega  3  fatty  acids
demonstrated positive effects on ROP outcome [34]; however,
no  information  regarding  weight  gain  was  provided  in  that
report.  In  addition,  there  are  on-going  preventative  studies
evaluating supplementing preterm infants with DHA/EPA (EU-
nr  2008-000046-31)  and  IGF-I  (ClinicalTrials.gov  Id:
NCT01096784) in an attempt to improve postnatal growth and
normalize retinal angiogenesis.
The  strength  of  this  study  is  that  for  the  first  time  the
WINROP surveillance system have been evaluated in a nation-
based  cohort.  This  is  also  the  first  time  WINROP  has  been
evaluated in a cohort of selectively extremely preterm infant. A
limitation of this study is that the WINROP algorithm not yet
have been developed for infants born at a GA of 22 weeks,
consequently these infants had to be excluded from this study.
Further development and validations of the WINROP algorithm
have to be made before the infants born at a GA of 22 weeks
can be included in the surveillance system. Another limitation in
this study is the number of infants excluded, 16% (81/506), due
to  missing  weekly  weights  <  32  GA  weeks.  These  excluded
infants were more immature than the participating infants; their
median GA was 25 week and 1 day and their median BW was
730 g. One reason to this finding could be that more immature
infants have higher morbidity and weekly weight measurement
is  not  always  possible  to  perform  due  to  the  infants’  severe
illness. Since we have no data about the infants’ morbidity we
can only speculate that this is the reason to the 16% of infants
excluded due to missing weekly weight measurements.
The  web-based  weight-monitoring  ROP  screening  tool,
WINROP identified infants at high risk of sight-threatening ROP
type  1  at  an  early  stage  in  this  population-based  cohort  of
extremely  preterm  infants.  Using  WINROP  to  supplement
traditional ROP screening programs could significantly reduce
the number of stressful eye examinations for extremely preterm
infants who do not signal a WINROP alarm.
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